{
  "url": "https://openlegislation.uk/eu-directive-2010-92/annex",
  "json_url": "https://openlegislation.uk/eu-directive-2010-92/annex.json",
  "legislation": "eudr/2010/92",
  "legislation_title": "Commission Directive 2010/92/EU of 21 December 2010 amending Council Directive 91/414/EEC to include bromuconazole as active substance (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-directive-2010-92",
  "path": "annex",
  "kind": "annex",
  "number": null,
  "heading": null,
  "text": "The following entry shall be added at the end of the table in Annex I to Directive 91/414/EEC:\nFurther details on identity and specification of active substance are provided in the review report.\nNo\nCommon name, identification numbers\nIUPAC name\nPurity\nEntry into force\nExpiration of inclusion\nSpecific provisions\n‘323\nBromuconazole\nCAS No: 116255-48-2\nCIPAC No: 680\n1-[(2RS,4RS:2RS,4SR)-4-bromo-2-(2,4-dichlorophenyl)tetrahydrofurfuryl]-1H-1,2,4-triazole\n≥ 960 g/kg\n1 February 2011\n31 January 2021\nPART A\nOnly uses as fungicide may be authorised.\nPART B\nFor the implementation of the uniform principles of Annex VI, the conclusions of the review report on bromuconazole, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 23 November 2010 shall be taken into account.\nIn this overall assessment, Member States shall pay particular attention to:\noperator’s safety and ensure that conditions of use prescribe the application of adequate personal protective equipment where appropriate,\nprotection of aquatic organisms. Conditions of authorisation shall include risk mitigation measures, where appropriate, such as adequate buffer zones.\nThe Member States concerned shall ensure that the applicant presents to the Commission:\nfurther information on residues of triazole derivative metabolites (TDMs) in primary crops, rotational crops and products of animal origin,\ninformation to further address the long-term risk to herbivorous mammals.\nThey shall ensure that the applicant at whose request bromuconazole has been included in this Annex provides such confirmatory information to the Commission by 31 January 2013 at the latest.\nThe Member States concerned shall ensure that the applicant submits to the Commission further information addressing the potential endocrine disrupting properties of bromuconazole within two years after the adoption of the OECD test guidelines on endocrine disruption or, alternatively, of Community agreed test guidelines.’",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Further details on identity and specification of active substance are provided in the review report."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudr/2010/92/annex",
    "retrieved_at": "2026-11-01T14:42:04.720551+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}